当前位置:药药网 / 数据中心 / 儿科标签更改电子表格2021
Lumason
通用名称
Sulfur Hexafluoride Lipid-Type A Microspheres
儿科标签批准日期
2019/11/13 0:00:00
特定指示/秒
Use in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult and pediatric patients with suboptimal echocardiograms
标签更改摘要
- Safety and effectiveness have been established for use in pediatric patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve delineation of the left endocardial border.
- Safety and effectiveness in pediatric patients are based on adequate and well-controlled studies in adults and are supported by a clinical study in 12 pediatric patients with extrapolation of efficacy to younger pediatric patients.
- No new adverse reactions were reported in the pediatric study
- Safety of intravenous use of Lumason was based on evaluation of published literature involving the use of Lumason in over 1400 pediatric patients (0 to 17 years).
- Information on dosing, adverse reactions, and clinical trial.
- Postmarketing study.
治疗类别
Radioactive Diagnostic Agent